Status:
COMPLETED
Atomoxetine Treatment of Adults With ADHD and Comorbid Alcohol Abuse
Lead Sponsor:
Eli Lilly and Company
Conditions:
ADHD
Comorbid Alcohol Abuse
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Atomoxetine Treatment of Adults with ADHD and Comorbid Alcohol Abuse
Eligibility Criteria
Inclusion
- You must be at least 18 years old.
- You must have a diagnosis of ADHD and a diagnosis of alcohol abuse or dependence.
- You must have acceptable results on blood and urine tests and an electrocardiogram (ECG).
- Your recent drinking history must meet specific requirements.
Exclusion
- You have taken atomoxetine in the past.
- You have a psychiatric disorder, other than ADHD and alcohol abuse or dependence, for which you will need psychiatric medication.
- You have cognitive impairment (such as memory loss), a brain injury, or a seizure disorder.
- You have a history of severe allergies to more than 1 class of medication or multiple bad reaction to drugs.
Key Trial Info
Start Date :
August 1 2004
Trial Type :
INTERVENTIONAL
End Date :
January 1 2006
Estimated Enrollment :
140 Patients enrolled
Trial Details
Trial ID
NCT00190957
Start Date
August 1 2004
End Date
January 1 2006
Last Update
November 6 2007
Active Locations (15)
Enter a location and click search to find clinical trials sorted by distance.
1
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician
El Centro, California, United States
2
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician
Poway, California, United States
3
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician
San Diego, California, United States
4
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician
New London, Connecticut, United States